| Lois L Deaton, MD | |
|
2139 Auburn Ave, Cincinnati, OH 45219 | |
| (513) 585-3635 | |
| (513) 585-3189 |
| Full Name | Lois L Deaton |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 33 Years |
| Location | 2139 Auburn Ave, Cincinnati, Ohio |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578599213 | NPI | - | NPPES |
| P00370746 | Other | OH | RR MEDICARE |
| 0221272 | Medicaid | OH | |
| 64951718 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 35-069207 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christ Hospital | Cincinnati, OH | Hospital |
| Entity Name | L L Deaton Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336222736 PECOS PAC ID: 3779580584 Enrollment ID: O20061108000311 |
News Archive
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
People who have been unable to obtain health insurance in the commercial market because of pre-existing conditions can apply for a new, federally funded high-risk insurance pool beginning Thursday, The Wall Street Journal reports. "The program is the first major plank of the health overhaul signed into law in March, and it's designed as a temporary provision to expand coverage until 2014, when a requirement kicks in that insurers accept all applicants."
CONNECT(R), one of the nation's most successful organizations dedicated to creating and sustaining the growth of innovative technology and life science businesses, announced SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, as the winner of its 22nd annual Most Innovative New Product (MIP) Award for 2009.
Functional beverage manufacturers are acknowledging consumer demand for natural and organic beverages by investing in product innovation, new flavours, and the introduction of balanced nutrients and environment-friendly packages.
Researchers at the University of California, San Francisco have determined that there is a strong relationship between being obese and developing end-stage renal disease, or kidney failure.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lois L Deaton, MD Po Box 635526, Cincinnati, OH 45263-5526 Ph: (513) 585-3635 | Lois L Deaton, MD 2139 Auburn Ave, Cincinnati, OH 45219 Ph: (513) 585-3635 |
News Archive
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
People who have been unable to obtain health insurance in the commercial market because of pre-existing conditions can apply for a new, federally funded high-risk insurance pool beginning Thursday, The Wall Street Journal reports. "The program is the first major plank of the health overhaul signed into law in March, and it's designed as a temporary provision to expand coverage until 2014, when a requirement kicks in that insurers accept all applicants."
CONNECT(R), one of the nation's most successful organizations dedicated to creating and sustaining the growth of innovative technology and life science businesses, announced SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, as the winner of its 22nd annual Most Innovative New Product (MIP) Award for 2009.
Functional beverage manufacturers are acknowledging consumer demand for natural and organic beverages by investing in product innovation, new flavours, and the introduction of balanced nutrients and environment-friendly packages.
Researchers at the University of California, San Francisco have determined that there is a strong relationship between being obese and developing end-stage renal disease, or kidney failure.
› Verified 8 days ago
William Edward Walsh, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6200 Pfeiffer Rd, Fl 3, Cincinnati, OH 45242 Phone: 513-985-6793 Fax: 513-965-8091 | |
Dennis Roy Lockaby Jr., Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1400 Mallard Cove Dr, Cincinnati, OH 45246 Phone: 513-830-5014 | |
David J Kissel, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 6200 Pfeiffer Rd, Fl 3, Cincinnati, OH 45242 Phone: 513-985-6793 Fax: 513-965-8091 | |
Aarti A Singla, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 500 E Business Way, Cincinnati, OH 45241 Phone: 513-354-3700 Fax: 513-354-3705 | |
Dr. James Michael Plunkett, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3200 Vine St, 117, Cincinnati, OH 45220 Phone: 513-475-6323 Fax: 513-487-6624 | |
Dr. Francis Clifford Valentin, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 7910 Beechmont Ave, Cincinnati, OH 45255 Phone: 513-232-2663 Fax: 859-817-7848 | |
Michelle Miller, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1701 Llanfair Ave # Oh, Cincinnati, OH 45224 Phone: 513-681-4230 |